Strengths

● The earnings growth currently anticipated by analysts for the coming years is particularly strong.

● The stock, which is currently worth 2022 to 0.18 times its sales, is clearly overvalued in comparison with peers.

● The company's share price in relation to its net book value makes it look relatively cheap.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.


Weaknesses

● As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.

● Low profitability weakens the company.

● With an expected P/E ratio at 166 and 19.76 respectively for both the current and next fiscal years, the company operates with high earnings multiples.

● The valuation of the company is particularly high given the cash flows generated by its activity.

● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

● For the past year, analysts have significantly revised downwards their profit estimates.

● For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.

● The company's earnings releases usually do not meet expectations.